That portfolio of stocks I've been building since September 3, 2019, named Volio will, by Friday, August 28, hold 52 dividend dogs. Volio is the fifth portfolio I've built (at a one dividend dog per-week pace) since 2014. Five portfolios = V for Volio!

Today I'm reviewing the second of five healthcare sector stocks primed to join Volio as the fifth of five representing the sector.One of the stocks I discuss this week could become the fifty-second and last overall selection for Volio! 

My subject today is small-cap medical instruments and supplies company named, LeMaitre Vascular Inc. Its trading ticker is LMAT. This is my first report on LeMaitre Vascular Inc (LMAT) for any portfolio. 

LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are primarily used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. 

The firm's lower extremities product line contributes the largest proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems.

LeMaitre generates the majority of its revenue in the United States. Sales in Germany also contribute a significant proportion of total revenue.

The company marks ts its products through a direct sales force and distributors. 

The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. 

LeMaitre Vascular, Inc. was founded in 1983 and is headquartered in Burlington, Massachusetts.

I use three key data points to gauge dividend equities or funds like LeMaitre Vascular Inc. (LMAT):

(1) Price

(2) Dividends

(3) Returns

Those three basic keys best tell whether a company has made, is making, and will make money. 

LMAT Price

LaMaitre's price per share closed at $29.37 yesterday. A year ago its price was $31.71. Price fell by $2.34 or about 7.4% last year.

Assuming LaMaitre's stock trades in the range of $20 to $35 this next year, its recent $29.37 price might rise by $4.63 to reach $34.00 by August 25, 2021. 

LMAT Dividends

LaMaitre's most recently declared quarterly dividend was $0.095, payable September 10th. That Q dividend equates to $0.38annually and yields 1.29% at yesterday's $29.37 share price. 

WBA Gains?

Adding the $0.38 annual estimated dividend to my $4.63 optimistic estimate of LaMaitre's price upside shows a $5.01 potential gross gain, per share, to be reduced by any costs to trade the shares.  

If we put a little under $1,000.00 today in LeMaitre Vascular Inc. at $29.37, we would buy 34 shares of (LMAT) stock.

A $10 broker fee paid half at purchase and half at sale could cost us about $0.34 per share.

Subtract that $0.34 brokerage cost from my estimated $5.01 gross gain per share results in a net gain of $4.67 X 34 shares = $158.78 for a 15.9% net gain on a $998.58 investment.

Thus, LeMaitre Vascular Inc. (LMAT) shows a possible 15.9% net gain including a 1.29% dividend yield. It could be more, it could be less. 

The above speculation is based on past performance and supposition. Only time and money invested will tell if LeMaitre Vascular Inc. (LMAT) is worth it.